Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 8, 2003
- Sales of Generic Pravastatin, Simvastatin Sluggish So Far: Survey
September 8, 2003
- JCR Licenses MSC Technology from Osiris Therapeutics of US
September 8, 2003
- Sankyo to Begin Implementing RDRD Project This Year
September 8, 2003
- Sosei Balances R&D Risk with 7 Compounds in Pipeline
September 8, 2003
- AstraZeneca to Build Marketing System in CNS Field via Zomig
September 8, 2003
- Candesartan Reduces Chronic Heart Failure: ESC Meeting
September 8, 2003
- Asahi Kasei Pharma to Specialize in Brain/CNS, Urology, Bones
September 8, 2003
- Takara Bio Succeeds in Enhancing Production of Activated Lymphocytes
September 8, 2003
- CROs Prefer Experienced People Over New Grads: Survey
September 8, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
September 8, 2003
- BUSINESS NEWS IN BRIEF
September 8, 2003
- Press Seminar
September 8, 2003
- New Waves in the Generic Drug Industry (1)
September 8, 2003
- NEW PRODUCTS
September 8, 2003
- Financial Results in 1st Quarter
September 8, 2003
- MEDICAL DEVICE NEWS IN BRIEF
September 8, 2003
- Korosho Budget Request for 2004 Totals \20 Trillion
September 8, 2003
- OTC NEWS IN BRIEF
September 8, 2003
- Korosho Calls For Attention to ADRs due to Tamiflu, Diovan
September 8, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…